诺瓦瓦克斯医药（NVAX）股价在盘前交易时段大幅上涨6.1%，引发市场关注。与此同时，知名维权投资机构Shah Capital公开表示，将在公司即将举行的股东大会上对高管薪酬方案及董事会候选人名单投下反对票。
这一股价异动与股东积极行动同时出现，凸显了市场对诺瓦瓦克斯医药公司治理状况的高度关注。Shah Capital作为长期关注公司治理的活跃投资者，此次采取反对立场可能影响其他机构投资者的投票决策。
目前，诺瓦瓦克斯医药尚未就此事发表官方评论。市场分析师指出，此类股东行动通常反映了投资者对公司战略方向或管理层表现的不满，可能促使公司重新评估其治理结构。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.